GenSight KOL Event June

New York, June 12, 2018
Register for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

GenSight Biologics [SIGHT:PA] €57 MM MCap
Gene ther­a­py: reti­nal & CNS de­gen­er­a­tive patholo­gies and mi­to­chon­drial dis­ease. Lead, GS010, Ph 3 for Le­ber Hered­i­tary Op­tic Neu­ro­pa­thy (LHON). RE­V­ERSE Ph 3 to­p­line da­ta an­nounced Apr 2018, RES­CUE Ph... [more in­for­ma­tion]